☆Vivo Capital, LLC
Quality Q
0.284
AUM ($M)
1,095
Positions
47
Turnover
0.27
Top-10 wt
52%
Herfindahl
0.041
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 53 positions · portfolio value $1,095M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆TRVI funds › | Trevi Therapeutics Inc | HOLD | — | 8.7% | +3.6% | 95.0 | 5,094,668 | +0 | 5 | — |
| ☆PRAX funds › | Praxis Precision Medicines | TRIM | — | 8.3% | -0.8% | 90.8 | 271,116 | -67,779 | 5 | — |
| ☆ERAS funds › | Erasca Inc | TRIM | — | 6.9% | -9.5% | 75.6 | 4,127,412 | -8,024,068 | 5 | — |
| ☆AVBP funds › | Arrivent BioPharma Inc | ADD | — | 5.3% | +3.6% | 58.4 | 1,682,097 | +796,181 | 2 | — |
| ☆ABVX funds › | Abivax SA - ADR | ADD | — | 5.0% | +2.8% | 55.3 | 414,899 | +175,360 | 4 | — |
| ☆TNGX funds › | Tango Therapeutics Inc | TRIM | — | 3.9% | +0.2% | 43.1 | 1,379,769 | -775,011 | 5 | — |
| ☆CRVS funds › | Corvus Pharmaceuticals Inc | HOLD | — | 3.8% | +0.4% | 41.9 | 2,805,816 | +0 | 5 | — |
| ☆DRUG funds › | Bright Minds Biosciences Inc | HOLD | — | 3.6% | +0.2% | 39.1 | 557,172 | +0 | 5 | — |
| ☆CUSIP:P8696W104 funds › | Sinovac Biotech Ltd. | HOLD | — | 3.5% | +0.3% | 38.2 | 5,903,000 | +0 | 5 | — |
| ☆TENX funds › | Tenax Therapeutics Inc | ADD | — | 3.3% | +3.0% | 36.4 | 2,500,000 | +2,291,667 | 5 | — |
| ☆ACRS funds › | Aclaris Therapeutics, Inc. | ADD | — | 3.2% | +1.1% | 35.4 | 6,694,637 | +27,971 | 5 | — |
| ☆DYN funds › | Dyne Therapeutics Inc | HOLD | — | 3.2% | +0.8% | 34.6 | 1,557,466 | +0 | 5 | — |
| ☆DNTH funds › | Dianthus Therapeutics Inc | HOLD | — | 3.2% | +0.7% | 34.5 | 353,998 | +0 | 4 | — |
| ☆ANRO funds › | Alto Neuroscience Inc | ADD | — | 2.9% | +1.0% | 31.9 | 1,208,858 | +173,307 | 3 | — |
| ☆DBVT funds › | DBV Technologies SA | TRIM | — | 2.8% | -1.9% | 30.3 | 1,844,758 | -822,811 | 5 | — |
| ☆SABS funds › | SAB Biotherapeutics Inc | TRIM | — | 2.6% | -1.1% | 28.5 | 7,299,909 | -4,120,091 | 4 | — |
| ☆MLTX funds › | Moonlake Immunotherapeutics | ADD | — | 2.5% | +0.9% | 27.3 | 1,400,000 | +400,000 | 3 | — |
| ☆LBRX funds › | LB Pharmaceuticals Inc | HOLD | — | 2.4% | +0.7% | 26.0 | 800,000 | +0 | 4 | — |
| ☆NERV funds › | Minerva Neurosciences Inc | HOLD | — | 2.2% | +0.0% | 24.0 | 4,322,747 | +0 | 3 | — |
| ☆DSGN funds › | Design Therapeutics Inc | HOLD | — | 2.1% | +0.7% | 23.3 | 1,612,903 | +0 | 3 | — |
| ☆ORIC funds › | Oric Pharmaceuticals Inc | HOLD | — | 1.8% | -0.1% | 20.0 | 1,848,786 | +0 | 5 | — |
| ☆CAMP funds › | CAMP4 Therapeutics Corporation | HOLD | — | 1.7% | +0.1% | 18.6 | 4,246,568 | +0 | 4 | — |
| ☆FTH funds › | Faeth Therapeutics Inc | HOLD | — | 1.6% | -0.3% | 18.1 | 722,020 | +0 | 2 | — |
| ☆ACHV funds › | Achieve Life Sciences Inc. | NEW | — | 1.6% | +1.6% | 18.0 | 2,751,032 | +2,751,032 | 1 | — |
| ☆CMPX funds › | Compass Therapeutics Inc | TRIM | — | 1.6% | -2.7% | 17.0 | 7,757,060 | -1,788,406 | 5 | — |
| ☆ANTX funds › | AN2 Therapeutics Inc | HOLD | — | 1.4% | +0.5% | 15.3 | 3,153,640 | +0 | 2 | — |
| ☆EDIT funds › | Editas Medicine Inc | NEW | — | 1.1% | +1.1% | 11.5 | 3,555,250 | +3,555,250 | 1 | — |
| ☆GERN funds › | Geron Corp | HOLD | — | 1.0% | -0.1% | 11.1 | 8,671,797 | +0 | 5 | — |
| ☆ODTX funds › | Odyssey Therapeutics Inc | NEW | — | 1.0% | +1.0% | 10.8 | 575,000 | +575,000 | 1 | — |
| ☆EPRX funds › | Eupraxia Pharmaceuticals Inc | HOLD | — | 0.8% | -0.0% | 8.9 | 1,350,000 | +0 | 4 | — |
| ☆OKUR funds › | Onkure Therapeutics Inc | HOLD | — | 0.8% | +0.1% | 8.8 | 1,927,710 | +0 | 2 | — |
| ☆OLMA funds › | Olema Pharmaceuticals Inc | HOLD | — | 0.8% | -0.1% | 8.4 | 671,843 | +0 | 5 | — |
| ☆MNPR funds › | Monopar Therapeutics Inc | HOLD | — | 0.8% | +0.4% | 8.4 | 90,500 | +0 | 4 | — |
| ☆AURA funds › | Aura Biosciences Inc | NEW | — | 0.8% | +0.8% | 8.3 | 1,166,667 | +1,166,667 | 1 | — |
| ☆SRZN funds › | Surrozen Inc | HOLD | — | 0.6% | -0.0% | 6.7 | 260,000 | +0 | 5 | — |
| ☆ALXO funds › | ALX Oncology Holdings Inc | HOLD | Common Stock | 0.6% | +0.1% | 6.6 | 3,184,713 | +0 | 2 | — |
| ☆MSLE funds › | Satellos Bioscience Inc | NEW | — | 0.6% | +0.6% | 6.3 | 813,666 | +813,666 | 1 | — |
| ☆AVTX funds › | Avalo Therapeutics Inc | NEW | — | 0.5% | +0.5% | 5.1 | 275,000 | +275,000 | 1 | — |
| ☆PEPG funds › | Pepgen Inc | HOLD | — | 0.4% | +0.0% | 4.2 | 2,325,000 | +0 | 4 | — |
| ☆VALN funds › | Valneva SE | NEW | — | 0.4% | +0.4% | 4.0 | 763,199 | +763,199 | 1 | — |
| ☆SERA funds › | Sera Prognostics Inc | HOLD | — | 0.3% | -0.0% | 3.0 | 1,650,440 | +0 | 5 | — |
| ☆UNCY funds › | Unicycive Therapeutics | TRIM | — | 0.2% | -0.7% | 2.6 | 550,000 | -1,239,916 | 5 | — |
| ☆TIL funds › | Instil Bio Inc | HOLD | — | 0.2% | +0.0% | 2.3 | 292,743 | +0 | 5 | — |
| ☆INM funds › | InMed Pharmaceuticals Inc | NEW | — | 0.1% | +0.1% | 1.2 | 798,377 | +798,377 | 1 | — |
| ☆CUSIP:097702203 funds › | Bolt Biotherapeutics Inc | HOLD | — | 0.0% | +0.0% | 0.3 | 72,414 | +0 | 5 | — |
| ☆KTTA funds › | Pasithea Therapeutics Corp | TRIM | — | 0.0% | -0.1% | 0.2 | 465,471 | -1,634,529 | 3 | — |
| ☆DTIL funds › | Precision Biosciences Inc | HOLD | — | 0.0% | +0.0% | 0.0 | 4,675 | +0 | 5 | — |
| ☆COGT funds › | Cogent Biosciences Inc | EXIT | — | 0.0% | -1.4% | 0.0 | 0 | -422,300 | 0 | — |
| ☆CUSIP:834203309 funds › | Soleno Therapeutics Inc | EXIT | — | 0.0% | -0.8% | 0.0 | 0 | -294,909 | 0 | — |
| ☆CMPS funds › | Compass Pathway PLC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -200,000 | 0 | — |
| ☆CUSIP:880881107 funds › | Terns Pharmaceuticals Inc | EXIT | — | 0.0% | -5.9% | 0.0 | 0 | -1,334,418 | 0 | — |
| ☆MANE funds › | Veradermics Inc | EXIT | — | 0.0% | -1.6% | 0.0 | 0 | -300,000 | 0 | — |
| ☆VRDN funds › | Viridian Therapeutics Inc | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -166,288 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 1,095 | 47 | 0.27 | 52% | 0.041 | 0.279 | — | in |
| 2026Q1 | 1,198 | 45 | 0.42 | 60% | 0.057 | 0.154 | — | in |
| 2025Q4 | 1,547 | 47 | 0.35 | 60% | 0.059 | 0.233 | — | in |
| 2025Q3 | 1,243 | 47 | 0.30 | 58% | 0.055 | 0.272 | — | in |
| 2025Q2 | 977 | 42 | 0.18 | 75% | 0.147 | 0.682 | — | entered |
| 2025Q1 | 755 | 40 | 0.00 | 75% | 0.202 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status